Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$164.66 - $218.08 $1.35 Million - $1.78 Million
-8,177 Reduced 13.89%
50,696 $8.57 Million
Q2 2023

Aug 09, 2023

BUY
$176.32 - $240.22 $779,158 - $1.06 Million
4,419 Added 8.12%
58,873 $12.8 Million
Q1 2023

May 12, 2023

BUY
$161.33 - $204.36 $1.47 Million - $1.87 Million
9,128 Added 20.14%
54,454 $9.89 Million
Q4 2022

Feb 08, 2023

BUY
$191.53 - $236.82 $156,671 - $193,718
818 Added 1.84%
45,326 $8.91 Million
Q3 2022

Nov 09, 2022

BUY
$123.79 - $277.42 $5.51 Million - $12.3 Million
44,508 New
44,508 $10 Million
Q2 2021

Aug 13, 2021

SELL
$107.45 - $135.95 $3.45 Million - $4.36 Million
-32,100 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$75.23 - $109.23 $272,934 - $396,286
-3,628 Reduced 10.15%
32,100 $3.26 Million
Q3 2020

Nov 05, 2020

BUY
$71.31 - $109.74 $99,834 - $153,636
1,400 Added 4.08%
35,728 $2.76 Million
Q2 2020

Aug 12, 2020

BUY
$62.14 - $117.21 $1.23 Million - $2.31 Million
19,739 Added 135.3%
34,328 $3.83 Million
Q1 2020

May 12, 2020

BUY
$60.41 - $115.92 $199,353 - $382,536
3,300 Added 29.23%
14,589 $1.05 Million
Q4 2019

Jan 27, 2020

BUY
$11.44 - $123.99 $129,146 - $1.4 Million
11,289 New
11,289 $851,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.